AR222019A1 - Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina - Google Patents

Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina

Info

Publication number
AR222019A1
AR222019A1 AR273692A AR27369278A AR222019A1 AR 222019 A1 AR222019 A1 AR 222019A1 AR 273692 A AR273692 A AR 273692A AR 27369278 A AR27369278 A AR 27369278A AR 222019 A1 AR222019 A1 AR 222019A1
Authority
AR
Argentina
Prior art keywords
hydroxy
phenyl
substituted
procedure
preparation
Prior art date
Application number
AR273692A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR222019A1 publication Critical patent/AR222019A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
AR273692A 1977-09-13 1978-09-13 Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina AR222019A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/832,869 US4147872A (en) 1977-09-13 1977-09-13 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Publications (1)

Publication Number Publication Date
AR222019A1 true AR222019A1 (es) 1981-04-15

Family

ID=25262819

Family Applications (2)

Application Number Title Priority Date Filing Date
AR273692A AR222019A1 (es) 1977-09-13 1978-09-13 Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina
AR277236A AR220567A1 (es) 1977-09-13 1979-07-10 Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR277236A AR220567A1 (es) 1977-09-13 1979-07-10 Procedimiento para la preparacion de derivados de 3-((2,4-disustituido)-fenil)-piperidina

Country Status (23)

Country Link
US (1) US4147872A (de)
JP (5) JPS5935397B2 (de)
AR (2) AR222019A1 (de)
AT (1) AT368753B (de)
AU (1) AU507953B1 (de)
BE (1) BE870403A (de)
CA (1) CA1113463A (de)
CH (1) CH638187A5 (de)
DE (1) DE2839883A1 (de)
DK (1) DK401078A (de)
ES (2) ES473287A1 (de)
FI (1) FI66173C (de)
FR (4) FR2401913A1 (de)
GB (1) GB2004548B (de)
IE (1) IE47717B1 (de)
IL (1) IL55555A (de)
IT (1) IT1099026B (de)
LU (1) LU80219A1 (de)
NL (1) NL7809272A (de)
PH (1) PH15372A (de)
PT (1) PT68542A (de)
SE (2) SE7809606L (de)
YU (1) YU215678A (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FI792076A (fi) * 1978-07-05 1980-01-06 Ciba Geigy Ag Foerfarande foer framstaellning av nya fenylpiperidinderivat
US4302590A (en) * 1979-02-23 1981-11-24 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for the preparation of 4-aryloxy-3-phenylpiperidines
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
ZA821888B (en) * 1981-04-01 1983-02-23 Haessle Ab Novel phenyl-piperidines
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2495903A1 (en) * 2002-08-23 2004-03-04 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CA2900309A1 (fr) * 2013-02-14 2014-08-21 Galderma Research & Development Procede de synthese de 4-piperidin-4-yl-benzene-1,3-diol et de ses sels et nouveau compose 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate de tert-butyle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments

Also Published As

Publication number Publication date
DK401078A (da) 1979-03-14
JPS5538365A (en) 1980-03-17
FI66173B (fi) 1984-05-31
JPS5492973A (en) 1979-07-23
FR2412531B1 (de) 1983-01-14
JPS5935397B2 (ja) 1984-08-28
AT368753B (de) 1982-11-10
GB2004548A (en) 1979-04-04
CH638187A5 (fr) 1983-09-15
IE781837L (en) 1979-03-13
DE2839883A1 (de) 1979-03-15
BE870403A (fr) 1979-03-12
IL55555A0 (en) 1978-12-17
FR2412531A1 (fr) 1979-07-20
SE8305422D0 (sv) 1983-10-03
FR2412529B1 (de) 1983-01-14
FR2412530A1 (fr) 1979-07-20
PH15372A (en) 1982-12-10
LU80219A1 (fr) 1980-04-21
FR2412530B1 (de) 1982-11-12
JPS5640155B2 (de) 1981-09-18
IT7827557A0 (it) 1978-09-12
AU507953B1 (en) 1980-03-06
IL55555A (en) 1982-08-31
YU215678A (en) 1983-06-30
AR220567A1 (es) 1980-11-14
IT1099026B (it) 1985-09-18
SE7809606L (sv) 1979-03-14
CA1113463A (en) 1981-12-01
JPS5495577A (en) 1979-07-28
FI782793A (fi) 1979-03-14
FR2401913B1 (de) 1983-01-21
FR2412529A1 (fr) 1979-07-20
IE47717B1 (en) 1984-05-30
GB2004548B (en) 1982-03-24
SE8305422L (sv) 1983-10-03
JPS5463086A (en) 1979-05-21
US4147872A (en) 1979-04-03
PT68542A (en) 1978-10-01
ES473287A1 (es) 1980-03-01
NL7809272A (nl) 1979-03-15
ES480151A1 (es) 1980-04-01
JPS5538366A (en) 1980-03-17
FI66173C (fi) 1984-09-10
FR2401913A1 (fr) 1979-03-30
ATA658078A (de) 1982-03-15

Similar Documents

Publication Publication Date Title
AR222019A1 (es) Procedimiento para la preparacion de derivados de 3-(2-hidroxi-4-fenilo(sustituido))-3-hidroxi piperidina o-1,2,5,6-tetrahidropiridina
MX3591E (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
AR222481A1 (es) Procedimiento para obtener derivados de 1-(omega-alcanoiltio o omega-mercaptoalconoil)3,4-deshidroprolina
AR220004A1 (es) Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
AR216937A1 (es) Procedimiento para la preparacion de 1,1,1,2-tetrafluoretano
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
ES508024A0 (es) "procedimiento para preparar derivados de dihidropiridina".
AR225666A1 (es) Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR217688A1 (es) Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol
AR225611A1 (es) Procedimiento para la obtencion de nuevos derivados 5-halogen-6-(2',4'-dihalofenoxi)-1(o 3)-sustituido-2h-1,3-dihidrobenzimidazol-2-tiona,o similares
AR218498A1 (es) Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona
AR220120A1 (es) Procedimiento para la fabricacion de derivados de 1-alquil-4-(n-acetil)amino-tetrahidro-1,3,5-triazol-2,6-diona
AR209672A1 (es) Procedimiento de preparacion de 4-(2-sustituido-3-piridil)-,3,5-dicarboalcoxi-2,-dimetil-1,4-dihidropiridinas
ES493931A0 (es) Procedimiento de preparacion de nuevos derivados de la 3,4,5-trimetoxi-cinamoil-piperazina
AR229087A1 (es) Procedimiento para preparar derivados de 4-(substituido)tio-1-beta-d-ribofuranosilpirazolo(3,4-d)pirimidina
AR217335A1 (es) Procedimiento para preparar derivados de la 2,6-difenil-3,7-dioxabiciclo-(3,3,0)-octano-4,8-diona
MX6120E (es) Procedimiento mejorado para preparar derivados de 1-(3-(3,4,5-trimetoxifenoxi)-2-hidroxipropil)-4-aril-piperazina
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido
ES493591A0 (es) Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina
MX5454E (es) Procedimiento para preparar derivados de la 1,2,4-triazin-5-ona
MX5105E (es) Proceso para la preparacion de 3-fenoxibencil,3-(2,2-dihalo-vinilo)-2,2-dimetilciclopropanocarboxilato
AR220228A1 (es) Procedimiento para la preparacion de derivados de tiazin-1,3-(3,4-b)-isoquinoleina